Serum Procalcitonin Study in the Management of Ventilated Patients
Completed
Conditions studied: Ventilator Associated Pneumonia
In brief
The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.
Key facts
- Study ID
- NCT00726167
- Run by
- University of Missouri-Columbia
- People needed
- 29
- Starts
- 2008-09-01
- Expected to finish
- 2014-08-01
- Last updated by the study team
- 2016-10-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Are willing to give or who's proxy is willing to consent to be a study subject
- Are at least 18 years of age;
- Who are mechanically ventilated surgical intensive care unit patients.
You may not qualify if…
- Participation in any investigational device or drug trial within 30 days prior to enrollment.
Where it is running
- University of Missouri — Columbia, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.